000 01427 a2200349 4500
005 20250514045342.0
264 0 _c20030305
008 200303s 0 0 eng d
022 _a0160-2446
024 7 _a10.1097/00005344-200210000-00015
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDelbosc, Sandrine
245 0 0 _aStatins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes.
_h[electronic resource]
260 _bJournal of cardiovascular pharmacology
_cOct 2002
300 _a611-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl CoA Reductases
_xmetabolism
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xpharmacology
650 0 4 _aMonocytes
_xdrug effects
650 0 4 _aNADPH Oxidases
_xantagonists & inhibitors
650 0 4 _aSuperoxides
_xantagonists & inhibitors
650 0 4 _aTumor Cells, Cultured
_xdrug effects
700 1 _aMorena, Marion
700 1 _aDjouad, Farida
700 1 _aLedoucen, Christian
700 1 _aDescomps, Bernard
700 1 _aCristol, Jean-Paul
773 0 _tJournal of cardiovascular pharmacology
_gvol. 40
_gno. 4
_gp. 611-7
856 4 0 _uhttps://doi.org/10.1097/00005344-200210000-00015
_zAvailable from publisher's website
999 _c12164962
_d12164962